Pulmatrix Announces Third Quarter 2024 Financial Results and …

Nov 8, 2024 · Third Quarter 2024 Financial Results Revenues decreased approximately $1.4 million to $0.4 million for the three months ended September 30, 2024 , compared to $1.8 …

CouponFollow Extension

$1
OFF

Pulmatrix Announces Third Quarter 2024 Financial Results And …

1 week from now

Nov 8, 2024 · Third Quarter 2024 Financial Results Revenues decreased approximately $1.4 million to $0.4 million for the three months ended September 30, 2024 , compared to $1.8 …

prnewswire.com

$0
OFF

Press Releases - Pulmatrix

1 week from now

Nov 10, 2022 · Third Quarter 2022 Financial Results Revenues increased $0.8 million to $1.9 million for the three months ended September 30, 2022 compared to $1.1 million for the same …

pulmatrix.com

$16
OFF

Pulmatrix, Inc. (PULM) Stock Price, Quote & News - Stock Analysis

1 week from now

Nov 8, 2024 · Pulmatrix Announces First Quarter 2024 Financial Results and Provides Corporate Update. $16.3 million in cash and cash equivalents at the end of Q1 2024 providing projected …

stockanalysis.com

96%
OFF

Bit Digital, Inc. Announces Third Quarter Of Fiscal Year 2024 …

1 week from now

5 hours ago · Total revenue was $22.7 million for the Third Quarter of 2024, a 96% increase compared to the Third Quarter of 2023. The increase was primarily driven by the …

prnewswire.com

$38
OFF

Novavax Reports Third Quarter 2024 Financial Results And …

1 week from now

Sep 30, 2024 · Product sales of $38 million for the third quarter 2024 related to primarily U.S. market commercial sales. Licensing, royalties and other revenue of $46 million in the third …

novavax.com

$7
OFF

Eightco Announces Third Quarter 2024 Financial Results

1 week from now

3 days ago · Third quarter 2024 revenues of $7.7 million compared to $23.3 million for the prior year quarter, driven by reduction in capital available for cell phone sales after repayment of the …

globenewswire.com

34%
OFF

T2 Biosystems Announces Third Quarter 2024 Financial Results

1 week from now

3 days ago · Recent Financial and Commercial Highlights. Achieved third quarter total revenue of $2.0 million, representing an increase of 34% compared to the prior year period.

yahoo.com

FAQs about Pulmatrix Announces Third Quarter 2024 Financial Results and … Coupon?

How much cash does Pulmatrix have in 2022?

Cash and cash equivalents as of September 30, 2022 was $40.7 million. As of November 10, 2022, Pulmatrix expects its existing cash and cash equivalents will enable it to fund operating expenses and capital expenditure into the second quarter of 2024. ...

Will Pulmatrix fund operating expenses and capital expenditure in 2024?

As of November 10, 2022, Pulmatrix expects its existing cash and cash equivalents will enable it to fund operating expenses and capital expenditure into the second quarter of 2024. PULMATRIX, INC. PULMATRIX, INC. ...

Who is Pulmatrix?

PULMATRIX, INC. PULMATRIX, INC. Pulmatrix is a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSE™ technology. ...

When will Pulmatrix release a Phase 1 study data?

Phase 1 study database lock to occur in November with top-line data anticipated to be released in early Q1 2023. Pulmatrix is analyzing data from the completed Phase 1b clinical study of PUR1800 for AECOPD for presentation at a relevant medical conference in 2023. ...

What does Pulmatrix stand for?

LEXINGTON, Mass. , July 11, 2023 /PRNewswire/ -- Pulmatrix, Inc. ("Pulmatrix" or the "Company") (NASDAQ: PULM), a clinical-stage biopharmaceutical company developing innovative inhaled therapies to ad... ...

What is a Pulmatrix cross license?

Cross license involves Pulmatrix iSPERSE™ technology and MannKind's Cricket® inhalation device. Pulmatrix transferring leased building, all leasehold improvements, laboratory equipment and other relat... ...